Briefly Bio emerged from stealth with a $1.2M pre-seed raise
Briefly Bio has developed a platform that streamlines scientific protocol creation and sharing, aiming to revolutionize research collaboration and lab automation by addressing the time-consuming challenge of experimental troubleshooting.
Briefly Bio, a platform that aims to become the GitHub for science, emerged from stealth Wednesday with news that it had secured $1.2 million in pre-seed funding. Briefly Bio aims to address one of the most important bottlenecks to implementing lab automation technologies: experimental troubleshooting. To do this, the startup has built a platform featuring capabilities geared towards scientists, managers, and lab automation engineers to streamline protocol creation, sharing, and execution, potentially transforming how scientists collaborate and automate their work.
Briefly Bio also aims to enable effective communication by supporting scientists and data scientists so they understand the context of the data they work with. This is a key feature of Briefly Bio's approach, as Compound, an investor in the company, sees Briefly Bio as addressing an underserved problem in the biotech software space. Compound envisions the platform developing network effects around its protocols similar to GitHub's sharing, collaborating, and forking. Compound also remarked on Briefly Bio's potential for growth, as protocol standards enforcement is also relevant outside academia and industry, making publishing and lab automation possible extensions of Briefly Bio's market reach.
